Morgan Stanley’s CollPlant Biotechnologies OPHI Stock Holding History

Morgan Stanley’s Portfolio OPHI Stock Details OPHI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Hold	0	–	-$1	–	7962
2026 Q2	–	Hold	0	–	–	–	8395
2026 Q1	–	Hold	0	–	–	–	8276
2025 Q4	–	Sell	-241	Closed	-$4.93K	–	8166
2025 Q3	$6.47K	Buy	+241	New	+$5.74K	﹤0.01%	7022
2025 Q2	–	Hold	0	–	–	–	8064
2025 Q1	–	Hold	0	–	–	–	8039
2024 Q4	–	Hold	0	–	–	–	7923
2024 Q3	–	Hold	0	–	–	–	7873
2024 Q2	–	Hold	0	–	–	–	7790
2024 Q1	–	Hold	0	–	–	–	7773
2023 Q4	–	Sell	-12	Closed	-$657	–	7748
2023 Q3	$674	Hold	12	–	–	﹤0.01%	7275
2023 Q2	$987	Sell	12 -5	-29%	-$364	﹤0.01%	7295
2023 Q1	$1.2K	Hold	17	–	–	﹤0.01%	7326
2022 Q4	$1.43K	Hold	17	–	–	﹤0.01%	7419
2022 Q3	$1K	Buy	17 +12	+240%	+$974	﹤0.01%	7550
2022 Q2	$0	Sell	5 -20	-80%	-$1.84K	﹤0.01%	7825
2022 Q1	$3K	Sell	25 -47	-65%	-$5.17K	﹤0.01%	7676
2021 Q4	$12K	Buy	72 +67	+1,340%	+$12K	﹤0.01%	7407
2021 Q3	$1K	Sell	5 -10	-67%	-$1.8K	﹤0.01%	7758
2021 Q2	$3K	Buy	+15	New	+$2.4K	﹤0.01%	7480

Other funds holding OPHI

St. Denis J. Villere & Co New Orleans, Louisiana $775M AUM 13.27% 1-Year Est. Return

Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Parkside Financial Bank & Trust Saint Louis, Missouri $1.51B AUM 17.86% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Strive Financial Group Carmel, Indiana $316M AUM 17.91% 1-Year Est. Return

Morgan Stanley's OPHI Position: Q3 2026 in Review

Morgan Stanley held its CollPlant Biotechnologies (OPHI) position steady in Q3 2026 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7962.

Morgan Stanley first reported a position in OPHI in Q2 2021 and has held it in 11 quarters since. The position peaked at $12K in Q4 2021. 7 funds tracked by Wall St. Rank hold OPHI as of Q3 2026.

Morgan Stanley held 0 shares of CollPlant Biotechnologies worth $0 as of Q3 2026.
Morgan Stanley left its CollPlant Biotechnologies share count unchanged in Q3 2026.
CollPlant Biotechnologies made up ﹤0.01% of Morgan Stanley's portfolio in Q3 2026, its #7962 holding.
Morgan Stanley first reported a position in CollPlant Biotechnologies in Q2 2021 and has held it in 11 quarters since.
Morgan Stanley's CollPlant Biotechnologies position peaked at $12K in Q4 2021.
7 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q3 2026.

Based on Morgan Stanley's 13F filing for Q3 2026, filed 13 Nov 2026.